Kodiak Sciences Inc. KOD
$33.52
▲ +0.26% 24H
About
Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics for retinal diseases. The company specializes in next-generation therapies targeting chronic, high-prevalence ophthalmic conditions that lead to vision loss, including wet…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees130
TickerKOD
Statistics
Market Cap$2.08B
Revenue (TTM)$0
Net Income-$230.0M
Net Margin—
EPS$-4.32
P/E-7.86
P/S—
P/B18.79
EV/EBITDA-9.16
ROE-208.8%
Dividend Yield—
Price$33.52
Data: Twelve Data · Revenue = mcap / P/S